{
    "nctId": "NCT02757651",
    "briefTitle": "KORTUC: Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response",
    "officialTitle": "Phase I 'Run in' Study Followed by Randomised Phase II Trial Testing Intra-tumoural Hydrogen Peroxide as a Radiation Sensitizer in Women With Locally Advanced/Recurrent Breast Cancer in Terms of Toxicity and Tumour Response",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE1, PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 12,
    "primaryOutcomeMeasure": "Phase I: Patient reported maximum intra-tumoural pain intensity over duration of treatment",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age over 18 years\n* Primary locally advanced breast cancer, or locally recurrent breast cancer with/without metastases\n* Radical/high dose palliative radiotherapy required for lifetime control of local morbidities\n* Patient physically and mentally fit for radical/high dose palliative radiotherapy\n* Target tumour accessible for intra-tumoural injection\n* At least one tumour diameter \u226530 mm measurable by ultrasound or magnetic resonance imaging\n* Patient available for minimum 3 months follow up post-treatment prior to any surgical resection\n* Negative pregnancy test within 7 days of starting radiotherapy in women of child bearing potential and an ability/willingness to protect against pregnancy for 3 months post- radiotherapy\n* Patient offers written informed consent\n\nExclusion Criteria:\n\n* Prior radiotherapy to the target area\n* Anatomical location \\&/or extent of disease difficult to access for safe intra-tumoural drug injections, for example by virtue of contiguous major blood vessels and/or brachial plexus",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}